Patent · US Expired

Ataxia-telangiectasia gene

US6211336A · kind A · utility

2Cited by
12References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 26, 1998
Grant dateApr 3, 2001
Priority date
Expiry dateFeb 26, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided a purified amino acid sequence selected from the group of Sequence ID No.: 3 and analogs thereof and mutations of Sequence ID No.: 3 which cause ataxia-telangiectasia. Also provided is a purified amino acid sequence as set forth in Sequence ID No.: 3 and analogs thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.